These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 17907447

  • 1. [Immune therapy against tumors based on the ubiquitin-proteasome pathway].
    Himeno K, Hisaeda H.
    Fukuoka Igaku Zasshi; 2007 Aug; 98(8):312-9. PubMed ID: 17907447
    [No Abstract] [Full Text] [Related]

  • 2. A novel DNA vaccine based on ubiquitin-proteasome pathway targeting 'self'-antigens expressed in melanoma/melanocyte.
    Zhang M, Obata C, Hisaeda H, Ishii K, Murata S, Chiba T, Tanaka K, Li Y, Furue M, Chou B, Imai T, Duan X, Himeno K.
    Gene Ther; 2005 Jul; 12(13):1049-57. PubMed ID: 15800663
    [Abstract] [Full Text] [Related]

  • 3. DNA gene fusion vaccines against cancer.
    Zhu D, Stevenson FK.
    Curr Opin Mol Ther; 2002 Feb; 4(1):41-8. PubMed ID: 11883694
    [Abstract] [Full Text] [Related]

  • 4. [Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy].
    Van den Eynde B.
    Bull Mem Acad R Med Belg; 2007 Feb; 162(5-6):352-6. PubMed ID: 18405005
    [Abstract] [Full Text] [Related]

  • 5. Roadmap to a better therapeutic tumor vaccine.
    Emens LA.
    Int Rev Immunol; 2006 Feb; 25(5-6):415-43. PubMed ID: 17169782
    [Abstract] [Full Text] [Related]

  • 6. DNA vaccines: precision tools for activating effective immunity against cancer.
    Rice J, Ottensmeier CH, Stevenson FK.
    Nat Rev Cancer; 2008 Feb; 8(2):108-20. PubMed ID: 18219306
    [Abstract] [Full Text] [Related]

  • 7. Maximizing antigen targeting to the proteasome for gene-based vaccines.
    Andersson HA, Barry MA.
    Mol Ther; 2004 Sep; 10(3):432-46. PubMed ID: 15336644
    [Abstract] [Full Text] [Related]

  • 8. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
    Lynch DH.
    Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Personalized cancer vaccines.
    Jain KK.
    Expert Opin Biol Ther; 2010 Dec; 10(12):1637-47. PubMed ID: 20979567
    [Abstract] [Full Text] [Related]

  • 11. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.
    Garcia-Hernandez Mde L, Gray A, Hubby B, Klinger OJ, Kast WM.
    Cancer Res; 2008 Feb 01; 68(3):861-9. PubMed ID: 18245488
    [Abstract] [Full Text] [Related]

  • 12. Cancer vaccines for established cancer: how to make them better?
    Andrews DM, Maraskovsky E, Smyth MJ.
    Immunol Rev; 2008 Apr 01; 222():242-55. PubMed ID: 18364006
    [Abstract] [Full Text] [Related]

  • 13. The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptides.
    Zhang XM, Zhang YF, Huang Y, Qu P, Ma B, Si SY, Li ZS, Li WX, Li X, Ge W, Hu PZ, Sui YF.
    Oncol Rep; 2008 Jul 01; 20(1):245-52. PubMed ID: 18575744
    [Abstract] [Full Text] [Related]

  • 14. Learning from the Proteasome How To Fine-Tune Cancer Immunotherapy.
    Vigneron N, Abi Habib J, Van den Eynde BJ.
    Trends Cancer; 2017 Oct 01; 3(10):726-741. PubMed ID: 28958390
    [Abstract] [Full Text] [Related]

  • 15. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct 01; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
    Durántez M, López-Vázquez AB, de Cerio AL, Huarte E, Casares N, Prieto J, Borrás-Cuesta F, Lasarte JJ, Sarobe P.
    Scand J Immunol; 2009 Feb 01; 69(2):80-9. PubMed ID: 19144076
    [Abstract] [Full Text] [Related]

  • 18. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
    Wang QM, Kang L, Wang XH.
    Microbiol Immunol; 2009 Jul 01; 53(7):384-90. PubMed ID: 19563397
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cell vaccine with mRNA targeted to the proteasome by polyubiquitination.
    Hosoi A, Takeda Y, Sakuta K, Ueha S, Kurachi M, Kimura K, Maekawa R, Kakimi K.
    Biochem Biophys Res Commun; 2008 Jun 27; 371(2):242-6. PubMed ID: 18423376
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.